1. Home
  2. AZTA vs NBTX Comparison

AZTA vs NBTX Comparison

Compare AZTA & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Azenta Inc.

AZTA

Azenta Inc.

HOLD

Current Price

$18.60

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$41.35

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AZTA
NBTX
Founded
1978
2003
Country
United States
France
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
AZTA
NBTX
Price
$18.60
$41.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$40.60
$36.00
AVG Volume (30 Days)
770.5K
50.0K
Earning Date
05-06-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
60.52
N/A
EPS
N/A
N/A
Revenue
$593,821,000.00
N/A
Revenue This Year
$6.99
$58.17
Revenue Next Year
$5.98
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.87
$3.34
52 Week High
$41.73
$41.89

Technical Indicators

Market Signals
Indicator
AZTA
NBTX
Relative Strength Index (RSI) 31.51 66.92
Support Level N/A $20.11
Resistance Level $32.32 $41.89
Average True Range (ATR) 1.45 1.74
MACD -0.43 0.50
Stochastic Oscillator 11.89 92.03

Price Performance

Historical Comparison
AZTA
NBTX

About AZTA Azenta Inc.

Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: